4//SEC Filing
ALDRICH RICHARD 4
Accession 0001209191-22-036282
CIK 0001367920other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:12 PM ET
Size
10.3 KB
Accession
0001209191-22-036282
Insider Transaction Report
Form 4
ALDRICH RICHARD
Director10% Owner
Transactions
- Award
Common Stock
2022-06-09+16,400→ 358,500 total - Award
Stock Option (right to buy)
2022-06-09+22,410→ 22,410 totalExercise: $5.00Exp: 2032-06-08→ Common Stock (22,410 underlying)
Holdings
- 44,351(indirect: By LLC)
Common Stock
- 210,526(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 9, 2023 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
- [F2]Not applicable.
- [F3]Shares held by the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich is the sole trustee of the Richard H. Aldrich 2018 Revocable Trust. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F4]Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are the Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- [F5]This option was granted based on Mr. Aldrich's election to receive his annual cash compensation in the form of a stock option.
- [F6]The shares underlying this option vest in equal quarterly installments over a one-year period through June 9, 2023, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 9, 2023).
Documents
Issuer
CONCERT PHARMACEUTICALS, INC.
CIK 0001367920
Entity typeother
Related Parties
1- filerCIK 0001185039
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:12 PM ET
- Size
- 10.3 KB